Diabetic Stroke Severity: Epigenetic Remodeling and Neuronal, Glial, and Vascular Dysfunction

Area of Science:

• Neuroscience
• Endocrinology
• Molecular Biology

Background:

• Type 1 diabetes (T1D) significantly impacts stroke outcomes, yet the underlying mechanisms remain unclear.
• Ischemia-reperfusion (IR) injury is a critical component of stroke pathology.
• Understanding T1D-specific alterations in brain tissue is crucial for targeted therapies.

Purpose of the Study:

• To elucidate the mechanism of increased severity in T1D stroke (IR injury) compared to non-diabetic stroke.
• To investigate epigenetic, neuronal, glial, and vascular changes in T1D stroke models.
• To identify potential biomarkers associated with T1D stroke severity.

Main Methods:

• Utilized male T1D Ins2(+/-) Akita and wild-type mice subjected to middle cerebral artery occlusion and reperfusion.
• Analyzed brain tissues for infarct volume, edema, inflammation, matrix metalloproteinase (MMP)-9, and epigenetic markers (DNMTs, 5-mC, 5-hmC).
• Assessed cerebrovascular integrity using fluorescein isothiocyanate-BSA infusion to determine pial-venular permeability.

Main Results:

• IR(Akita) mice exhibited significantly larger infarct volumes, increased edema, and heightened inflammation compared to IR and sham groups.
• Cerebrovascular impairment was severe in IR(Akita) mice, evidenced by reduced tight junction expression and increased venular leakage.
• Downregulated expression of epigenetic (DNMTs, 5-mC), vascular (eNOS), glial (Cx43, GFAP, CD11b), and neuronal (NSE, nNOS) markers was observed in IR(Akita) versus IR mice.

Conclusions:

• Ischemia-reperfusion injury in Type 1 diabetes is more severe due to intensified differential epigenetic and neuro-glio-vascular alterations.
• T1D exacerbates stroke pathology by dysregulating key molecular pathways involved in brain repair and inflammation.
• Findings highlight the critical role of epigenetic modifications and neuro-glio-vascular integrity in T1D stroke outcomes.